Print Page | Contact Us | Sign In | Register
2016 CE Mid-Winter Information
Share |

 

Pain Management in an Era of Uncertainty
Presenter:  Michael R. Brodeur, PharmD, CGP, FASCP
Associate Professor, Albany College of Pharmacy & Health Sciences
Program#: 0170-0000-16-003-L01-P
1 Contact Hour – Knowledge Based Activity
Initial Release Date: January 30, 2016
Target Audience: Pharmacists in all practice settings.
At the completion of this activity the participant will be able to:

  • discuss the latest information on the safety of NSAIDs (non-steroidal anti-inflammatory drugs);
  • describe strategies that can be utilized to effectively manage pain and minimize patient risk;
  • describe contemporary statistics with regards to opioid use, addiction and misuse;
  • describe strategies to identify and manage patients at risk for opioid overdose.

What’s New in Cardiology Literature: A Year in Review
Presenters: Kelly Rudd, PharmD, BCPS, CACP
Clinical Pharmacology Service Coordinator, Network Coordinator of Anticoagulation Services, Bassett Medical Center &
Amanda Engle, PharmD, BCPS
Clinical Pharmacy Specialist, Internal Medicine, Bassett Medical Center
Program#: 0170-0000-16-002-L01-P
1.5 Contact Hours– Knowledge Based Activity
Initial Release Date: January 30, 2016
Target Audience:  Pharmacists in all practice settings.
At the completion of this activity the participant will be able to:

  • identify/discuss new and emerging clinical data or patient care trends affecting pharmacotherapy and/or health outcomes in cardiology;
  • identify the limitations/controversies associated with these late breaking trials;
  • discuss approaches to apply and implement the new findings into practice.

New Drug Update 2015
Presenter: See Won-Seo, PharmD, BCACP, Assistant Professor of Ambulatory Care, Albany College of Pharmacy and Health Systems
Program #: 0170-0000-16-001-L01-P
1 Contact Hour– Knowledge Based Activity
Initial Release Date: January 30, 2016
Target Audience: Pharmacists in all practice settings.
At the completion of this activity the participant will be able to:

  • determine the efficacy of new drug approvals;
  • evaluate the safety of new drug approvals;distinguish the place of therapy of the new drug approvals in relation to
  • existing treatment in relation to relevance and innovation:
  • identify key counseling point of new drug approvals.

How to Survive a DEA Inspection Series: What Will Cause a DEA Administrative Action or a Pharmacy Civil Fine?
Presenters, James Schiffer, RPh, JD & Carlos Aquino,Compliance Consultant, PharmaDiversion
Program Number: 0170-0000-16-004-L03-P
2 Contact Hours
Initial Release Date: January 30, 2016
Target Audience: Pharmacists in all practice settings

At the completion of this activity, the participant will be able to:

  • define the role of DEA Diversion personnel who enforce pharmaceutical federal laws under the Controlled Substances Act and DEA regulations;
  • identify the civil actions and fines resulting from the failure to maintain complete and accurate records and continuous inventory;
  • identify each element of a DEA inspection which includes required DEA records security of controlled substances and the due diligence for dispensing;
  • describe and define the result of a revocation of a pharmacy DEA registration by citing the most recent results of DEA administrative hearings.

Update from the NYS Board of Pharmacy
Presenter: Lawrence Mokhiber, MS, RPh
Program #:  0170-0000-16-009-L03-P
1.5 Contact Hours - Knowledge Based Activity
Initial Release Date: January 30, 2016
Target Audience: Pharmacists in all practice settings.
At the completion of this activity the participant will be able to:

  • list the progress on the issue of pharmacy technicians in NYS;
  • state the changes to the immunization regulations for practicing pharmacists
  • identify the changes to the CDTM regulations and discuss how they apply to pharmacists;
  • list the e-prescribing impact in NYS and identify who is the prescriber agent.

 

Regulatory Update on Nutritional Supplements in NYS - How You Can Benefit
Presenter: Jack Koford, RPh, MBA, D'Youville College of Pharmacy
Program #: 0170-0000-16-008-L04-P
1 Contact Hour– Knowledge Based Activity
Initial Release Date: January 30, 2016
Target Audience: Pharmacists in all practice settings.
At the completion of this activity the participant will be able to:

  • discuss the Dietary Supplements Health and Education Act (DSHEA) and FDA regulation of supplements;
  • Discuss the regulatory environment of supplements in New York State;
  • List the strategies for verifying supplement quality and efficacy.

   
 The Pharmacists Society of the State of New York  and the American Pharmacists Association are accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.


APhA's MTM certification program is an active learning seminar in which participants practice a variety of communication techniques to elicit a patient's medication experience and identify medication-related problems, using cases based on the real-life experiences of MTM providers. Participants will gain experience interviewing patients, identifying and prioritizing medication-related problems, developing and implementing interventions, and documenting activities. In addition, participants will have the opportunity to explore various business models and billing strategies and discuss plans for implementation. Through additional pre-seminar self-study modules, case studies, hands-on patient interview, and assessment practice sessions, pharmacists will obtain the clinical knowledge and skills needed to establish medication therapy management services.

* Note: Must Complete Self-Study Program prior to live seminar. Recommended to register at least two weeks prior to the seminar.)

Fundamental Principles of Insulin Therapy  ∙   1.5 Contact Hours
Presenter: Samuel Grossman, BS, PharmD, CDE
Program #: 0069-9999-14-149-L01-P
1.5 Contact Hours
Program Release Date: 10/1/2014            Program Expiration Date: 10/1/2016

Program Objectives:
∙ explain the physiologic processes that necessitate insulin therapy in some adults with type 2 diabetes, the importance of keeping blood glucose levels at individualized targets and the role of insulin in optimizing gylcemic control;
∙ describe available insulin products and delivery devices;
∙ discuss effective approaches to initiating and titrating insulin therapy in adults with type 2 diabetes.
Program provided through mycecenter.com

Current Approaches to Preventing Chronic Diabetes Complications   ∙   1.5 Contact Hours

Presenter: Samuel Grossman, BS, PharmD, CDE
Program #: 0069-9999-15-018-L01-P
1.5 Contact Hours
Program Release Date: 4/1/2015               Program Expiration Date: 4/1/2017

Program Objectives:
∙ describe the major chronic complications of diabetes;
∙ review the epidemiology and impact of major chronic complications of diabetes in the United States;
∙ describe current approaches for preventing the development of major chronic complications of diabetes in adults with type 2 diabetes.

The American Association of Diabetes Educators is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

Medication Synchronization: Action Steps for Implementation
Program #: 0170-9999-15-195-L04-P
2 Contact Hours
Attendees to this activity will be able to:

  • Describe how medication synchronization can positively impact pharmacy financials, operations, as well as improve quality performance measures and patient care;
  • Outline how to integrate and appointment-based medication synchronization model into pharmacy workflow;
  • Discuss key success strategies that the pharmacy team can utilize when implementing a medication synchronization program;
  • Recall case studies of other independent pharmacies and their suggested steps for implementing and/or expanding your medication synchronization program;
  • Create and action plan to overcome any identified barriers to successful implementation of a medication synchronization program in your pharmacy.

    The Collaborative Education Institute is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.